Literature DB >> 8257215

Occurrence of arthritis in hyperimmunoglobulinaemia D.

J P Drenth, A M Prieur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8257215      PMCID： PMC1005177          DOI： 10.1136/ard.52.10.765-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Is onset type evaluated during the first 3 months of disease satisfactory for defining the sub-groups of juvenile chronic arthritis? A EULAR Cooperative Study (1983-1986).

Authors:  A M Prieur; B M Ansell; R Bardfeld; E Bhettay; I Bojkinov; K Denieskiewics; F Fantini; S Halvelka; H M Hoyeraal; J P Jais
Journal:  Clin Exp Rheumatol       Date:  1990 May-Jun       Impact factor: 4.473

2.  Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Authors:  J W van der Meer; J M Vossen; J Radl; J A van Nieuwkoop; C J Meyer; S Lobatto; R van Furth
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

3.  [Nosologic aspects of systemic forms of very early onset juvenile arthritis. Apropos of 17 cases].

Authors:  A M Prieur; C Griscelli
Journal:  Ann Pediatr (Paris)       Date:  1983-10

4.  Clinical and immunological studies in patients with an increased serum IgD level.

Authors:  I Hiemstra; J M Vossen; J W van der Meer; C M Weemaes; T A Out; B J Zegers
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317
  4 in total
  3 in total

1.  Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.

Authors:  I S Klasen; J H Göertz; G A van de Wiel; C M Weemaes; J W van der Meer; J P Drenth
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Atypical hypergammaglobulinaemia D syndrome with amyloidosis: an overlap with familial Mediterranean fever?

Authors:  P Ostuni; U Vertolli; P Marson
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

3.  B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome.

Authors:  M Sornsakrin; K Wenner; R Ganschow
Journal:  Eur J Pediatr       Date:  2008-10-07       Impact factor: 3.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.